Nature Communications (Aug 2017)

Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents

  • Junying Ma,
  • Hongbo Huang,
  • Yunchang Xie,
  • Zhiyong Liu,
  • Jin Zhao,
  • Chunyan Zhang,
  • Yanxi Jia,
  • Yun Zhang,
  • Hua Zhang,
  • Tianyu Zhang,
  • Jianhua Ju

DOI
https://doi.org/10.1038/s41467-017-00419-5
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 10

Abstract

Read online

Tuberculosis (TB) remains one of the world’s deadliest communicable diseases, novel anti-TB agents are urgently needed due to severe drug resistance and the co-epidemic of TB/HIV. Here, the authors show that anti-mycobacterial ilamycin congeners bearing unusual structural units possess extremely potent anti-tuberculosis activities.